Document:

Prepared by R.R. Donnelley Financial -- First Amendment to Stock Pledge Agreement

 Exhibit 10 (xv) 
  
 FIRST AMENDMENT TO 
 STOCK PLEDGE AGREEMENT 
  
 THIS FIRST AMENDMENT TO STOCK PLEDGE AGREEMENT dated as of January 9, 2002 (this “Amendment”) by and between MRY PARTNERS, L.P., a Georgia limited partnership (the “Pledgor”) and
NDCHEALTH CORPORATION (formerly known as National Data Corporation), a Delaware corporation (the “Pledgee”). 
  
 WHEREAS, the Pledgor and the Pledgee are parties to that certain Stock Pledge Agreement dated as of April 3, 2001 (the “Pledge Agreement”); 
  
 WHEREAS, the Pledgor and the Pledgee desire to amend the Pledge Agreement on the terms and conditions contained herein; 
  
 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto
hereby agree as follows: 
  
 SECTION 1.    Specific Amendment to Pledge
Agreement. 
  
 The Pledge Agreement is amended by adding the following new Section 24. to the end thereof:

  
 “SECTION 24.    Release of Collateral. 
  
 (a)  Notwithstanding anything contained in this Agreement to the contrary, so long as no Default or Event of Default has
occurred and is continuing, the Pledgor may request that the Pledgee, and the Pledgee shall, release its lien and security interest in a portion of the Securities and take such other action as may be reasonably necessary and requested by the Pledgor
to evidence such release; provided, however, that after giving effect to such release, the Fair Market Value of the Securities in which the Pledgee has a first priority, perfected security interest (the “Security Collateral Value”) shall
be equal to, or greater than, 125% of the amount of the then outstanding Secured Obligations (the “125% Threshold”); provided further, that, unless the Pledgee agrees otherwise, the Pledgor may make only one such request for release during
any consecutive three-month period. Any such request shall be in writing, shall specify in reasonable detail the Securities to be released and shall set forth such other information as the Pledgee shall reasonably request, such as the Pledgor’s
calculations of the Fair Market Value of the Securities and the 125% Threshold as of the date of such request and the source used to obtain the Fair Market Value of the Securities. 
  
 (b)  In the event that the Security Collateral Value at the end of any calendar quarter is less than the 125% Threshold, the Pledgor shall, on or before the
15th day of the first calendar month next succeeding such calendar quarter, provide the Pledgee a first
priority, perfected security interest in additional Collateral in the form of common stock of NDCHealth Corporation or other marketable securities acceptable to the Pledgee with a Fair Market Value sufficient to correct such deficiency.

  
 (c)  Upon any release of Collateral described in subsection (a) or addition of Collateral provided for
in subsection (b), Schedule 1 to the Pledge Agreement shall automatically be deemed to be amended to reflect such release or addition. 

  
 (d)  For the purposes hereof, “Fair Market Value” with
respect to any Security or other marketable security on any date means the fifty (50) day moving average value of such security as reported by any source specified by the Pledgor and reasonably acceptable to the Pledgee.” 

 
 SECTION 2.    Release of Securities.    The Pledgee hereby
releases its lien and security interest in 565,023 shares of the common stock of NDCHealth Corporation previously pledged by the Pledgor to the Pledgee and set forth on Schedule 1 to the Pledge Agreement. The Pledgee shall, upon the request of the
Pledgor, take such other action as may be reasonably necessary to evidence such release. Schedule 1 to the Pledge Agreement is hereby deemed amended to reflect such release. 
  
 SECTION 3.    Effectiveness.    The effectiveness of Sections 1 and 2 is subject to the truth and accuracy of
the representations set forth in Section 4 below and receipt by the Pledgee of counterparts of this Amendment duly executed by each of the parties hereto. 
  
 SECTION 4.    Representations of the Pledgor.    The Pledgor represents and warrants to the Pledgee that: 
  
 (a)  Authorization.    The Pledgor has the right and power, and has taken all
necessary action to authorize it, to execute, deliver and perform this Amendment. This Amendment has been duly executed and delivered by the general partner of the Pledgor and is a legal, valid and binding obligation of the Pledgor enforceable
against it in accordance with its respective terms. 
  
 (b)  Compliance of Loan
Documents with Laws, Etc.    The execution, delivery and performance of this Amendment, and the Loan Documents as amended by this Amendment, in accordance with their respective terms do not and will not, by the passage of
time, the giving of notice, or both: (i) require any governmental approval or violate any applicable law relating to the Pledgor; (ii) conflict with, result in a breach of or constitute a default under the partnership agreement of the Pledgor, or
any indenture, agreement or other instrument to which the Pledgor is a party or by which it or any of its properties may be bound, except as such conflict, breach or default shall have been waived in a writing presented to the Pledgee; or (iii)
result in or require the creation or imposition of any Lien upon or with respect to any property now owned or hereafter acquired by the Pledgor. 
  
 (c)  No Default.    No Default or Event of Default will exist immediately after giving effect to this Amendment. 
  
 SECTION 5.    Reaffirmation of Representations.    The Pledgor hereby
repeats and reaffirms all representations and warranties made by it to the Pledgee in the Loan Documents to which it is a party on and as of the date hereof (and after giving effect to this Amendment) with the same force and effect as if such
representations and warranties were set forth in this Amendment in full. 
  
 SECTION
6.    References to the Pledge Agreement.    Each reference to the Pledge Agreement in any of the Loan Documents (including the Pledge Agreement) shall be deemed to be a reference to the Pledge
Agreement, as amended by this Amendment. 
  
 SECTION
7.    Benefits.    This Amendment shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns. 
  
 SECTION 8.    GOVERNING LAW.    THIS AMENDMENT SHALL BE GOVERNED BY, AND
CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF GEORGIA. 

  
 SECTION
9.    Effect.    Except as expressly herein amended, the terms and conditions of the Pledge Agreement and the other Loan Documents shall remain in full force and effect. 
  
 SECTION 10.    Effective Date.    This Amendment shall not be effective
until its execution and delivery by the Pledgee and the Pledgor whereupon it shall be deemed effective as of January 9, 2002. 
  
 SECTION 11.    Counterparts.    This Amendment may be executed in any number of counterparts, each of which shall be deemed to be an original and shall be binding upon all
parties, their successors and assigns. 
  
 SECTION
12.    Definitions.    All capitalized terms not otherwise defined herein are used herein with the respective definitions given them in the Pledge Agreement. 
  
 IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to Stock Pledge Agreement to be executed as of the date first
above written. 
  
 
	 MRY PARTNERS, L.P.
 
	 
	 By:
 	 	 

	  	 	 Name:    Robert A. Yellowlees
 Title:    General Partner
 

 
  
 
	 NDCHEALTH CORPORATION
 
	 
	 By:
 	 	 

	  	 	 Name:    Patricia A. Wilson
 Title:    General CounselPrepared by R.R. Donnelley Financial -- First Amend to Revolving Credit Agreement

  
 Exhibit 10 (xvi) 
  
 FIRST AMENDMENT TO 
 REVOLVING CREDIT AGREEMENT 

 
 THIS FIRST AMENDMENT TO REVOLVING CREDIT AGREEMENT, dated as of May 24, 2002 (this “Amendment”), by and among
NDC HEALTH CORPORATION, a Delaware corporation (the “Borrower”), SUNTRUST BANK, a Georgia banking corporation (“SunTrust”), the other banks and lending institutions from time to time party thereto (SunTrust and such other banks
and lending institutions, individually a “Lender” and collectively, the “Lenders”), SunTrust in its capacity as Administrative Agent for the Lenders (the “Administrative Agent”), as Issuing Bank (the “Issuing
Bank”), and as Swingline Lender (the “Swingline Lender”), BANK OF AMERICA, N.A., in its capacity as Syndication Agent (the “Syndication Agent”), and WACHOVIA BANK, NATIONAL ASSOCIATION and U.S. BANK NATIONAL ASSOCIATION, in
their capacities as Co-Documentation Agents (the “Co-Documentation Agents”). 
  
 W I T N E S S E T H :

  
 WHEREAS, Borrower, Lenders, Administrative Agent, Issuing Bank, Swingline Lender, Syndication Agent and
Co-Documentation Agents are parties to that certain Revolving Credit Agreement, dated as of May 1, 2002 (as amended, restated, supplemented, or otherwise modified from time to time, the “Credit Agreement”); 
  
 WHEREAS, Borrower has requested that Administrative Agent and Lenders agree to amend the Credit Agreement so as to make certain changes in
the terms and conditions of the Credit Agreement as are more fully set forth herein.; 
  
 NOW, THEREFORE, in
consideration of the mutual promises and conditions contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound: 

 
 1.    Definitions.    Capitalized terms used but not otherwise defined herein
shall have the meanings given to such terms in the Credit Agreement. 
  
 2.    Amendment to
Section 1.1 of the Credit Agreement.    Section 1.1 of the Credit Agreement is hereby amended by adding the following as new definitions in proper alphabetical order: 
  
 “Scriptline Acquisition” shall mean the Acquisition by Borrower of the selected assets of Scriptline, a business unit of ArcLight Systems LLC, pursuant to
an Asset Purchase Agreement dated as of May 2002, between ArcLight Systems LLC and Borrower, to be consummated on or prior to May 31, 2002. 
  
 “TechRx Phase I Acquisition” shall mean the Acquisition by Borrower of a majority of the ownership interest of TechRx, Inc. pursuant to a Stock Purchase Agreement dated as of May

 

  
 2002, between TechRx, Inc. and Borrower, to be consummated on or prior to May 31, 2002. 

 
 3.    Amendment to Section 6.4 of the Credit Agreement.    Section 6.4 of the
Credit Agreement is hereby amended by deleting such Section 6.4 in its entirety and substituting the following in lieu thereof: 
  
 Section 6.4    Capital Expenditures.    The Borrower and its Subsidiaries may make Capital Expenditures during any Fiscal Year in an amount not to
exceed (i) $57,200,000 for the Fiscal Year ending May 30, 2003; (ii) $45,500,000 for the Fiscal Year ending May 31, 2004; and (iii) $48,500,000 for the Fiscal Year ending May 31, 2005; provided, however, commencing with the Fiscal Year
ending May 30, 2003, if the actual aggregate amount of Capital Expenditures made by the Borrower and its Subsidiaries during any Fiscal Year (the “Current CapEx”) is less than the respective limit specified above for such Fiscal Year (the
“Specified CapEx”), then the applicable limit for the immediately succeeding Fiscal Year shall be increased by an amount equal to the difference between the Current CapEx and the Specified CapEx (the “Carryover Amount”). For
purposes of this Section 6.4 Capital Expenditures made by the Borrower in any Fiscal Year shall be deemed to be made first with Specified CapEx for such Fiscal Year, then, from the Carryover Amount, if any. No Carryover Amount may be carried
over, however, beyond the immediately succeeding Fiscal Year. 
  
 4.    Amendment to Section
7.4(b) of the Credit Agreement.    Subsection 7.4(b) of the Credit Agreement is hereby amended by deleting such subsection 7.4(b) in its entirety and substituting the following in lieu thereof: 
  
 (b)    Without the prior written consent of the Required Lenders, the Borrower will not, nor will it
permit any of its Subsidiaries to, acquire, whether directly or through the purchase of stock, convertible notes or otherwise, or otherwise acquire any assets, other than (A) the Investments permitted by Section 7.4(a); (B) the assets of one
of its Subsidiaries; (C) fixed assets (which fixed assets do not constitute all or substantially all of the assets of the Person from whom such assets are acquired) or (D) Acquisitions, to the extent permitted in Section 7.4(c) below. 

 
 5.  Amendment to Section 7.4 of the Credit Agreement.    Section 7.4 of the Credit
Agreement is hereby amended by adding the following new subsection 7.4(c): 
  
 (c)    Without the prior written consent of the Required Lenders, the Borrower will not effect any Acquisitions, unless, in each case (A) such Acquisition is of a business which is similar (as to product sold or
service rendered) to the Borrower’s or any relevant Subsidiary’s; (B) such Acquisition is made upon a negotiated basis with the approval of the board of directors of the Person to be acquired, or of the percentage of ownership interests
required by the charter documents of such Person to approve any such Acquisition; (C) no Default or Event of Default shall be in existence or be caused thereby which has not been 
 

 2 

 specifically waived in writing pursuant to Section 10.2 (and, if requested by the Administrative Agent, the
Borrower has provided to the Administrative Agent a certificate to such effect, with supporting calculations of the financial covenants set forth in Sections 6.1 and 6.2 on a pro forma basis for the most recent four fiscal quarters of
the Borrower for which financial statements (annual or quarterly) are available after giving effect to such Acquisition as of the first day of such period, and the financial covenant set forth in Section 6.3 on a pro forma basis as of the end
of the most recent fiscal quarter of the Borrower for which financial statements (annual or quarterly) are available after giving effect to such Acquisition as of the end of such fiscal quarter); and (D) (x) if the Borrower fails to prepay the Loans
pursuant to Section 2.12 in an aggregate amount in excess of $50,000,000 during the 12 month period following the later of the consummation of the TechRx Phase I Acquisition or the Scriptline Acquisition (the “Post Acquisition
Period”), the then-current market value of all Capital Stock of the Borrower given as consideration in such Acquisition, if any, together with the aggregate value of all such Capital Stock given in respect of all other Acquisitions made shall
not exceed $50,000,000 or (y) if the Borrower shall prepay the Loans pursuant to Section 2.12 in an aggregate amount in excess of $50,000,000 during the Post Acquisition Period, (i) the total amount of cash consideration paid, and
Indebtedness assumed or otherwise becoming part of Consolidated Total Debt in such Acquisition shall not exceed $15,000,000, individually, or when aggregated with such cash consideration and assumed Indebtedness in respect of all other Acquisitions
made during the Post Acquisition Period shall not exceed $25,000,000; and (ii) the then-current market value of all Capital Stock of the Borrower given as consideration in such Acquisition, if any, together with the aggregate value of all such
Capital Stock given in respect of all other Acquisitions made during the Post Acquisition Period shall not exceed $50,000,000; provided, notwithstanding the foregoing, the Borrower shall in no case be allowed to effect more than two
Acquisitions during the Post Acquisition Period. 
  
 Provided, further, in addition to
the foregoing, the Borrower may effect up to four Acquisitions per Fiscal Year during the twenty-four (24) month period following the Post Acquisition Period, provided, in each case such Acquisition (x) complies with the requirements of
Sections 7.4(c)(A), (B) and (C); (y) the total amount of cash consideration paid, and Indebtedness assumed or otherwise becoming part of Consolidated Total Debt in such Acquisition shall not exceed $50,000,000, individually, or when aggregated with
such cash consideration and assumed Indebtedness in respect of all other Acquisitions made during the then-current Fiscal Year shall not exceed $75,000,000; and (z) the then-current market value of all Capital Stock of the Borrower given as
consideration in such Acquisition, if any, together with the aggregate value of all such Capital Stock given in respect of all other Acquisitions made during the then-current Fiscal Year shall not exceed $75,000,000. 
  
 Provided, further, notwithstanding the foregoing, the Borrower may effect the TechRx Phase I Acquisition and
the Scriptline Acquisition, provided, in each 
 

 3 

 case such Acquisition (w) complies with the requirements of Sections 7.4(c)(A), (B) and (C); (x) the total amount of cash
consideration paid, and Indebtedness assumed or otherwise becoming part of Consolidated Total Debt (i) for the TechRx Phase I Acquisition shall not exceed $54,000,000 and (ii) for the Scriptline Acquisition shall not exceed $81,000,000; (y) the
then-current market value of all Capital Stock of the Borrower given as consideration (i) for the TechRx Phase I Acquisition, if any, shall not exceed $12,000,000 and (ii) for the Scriptline Acquisition shall not exceed $0; and (z) each such
Acquisition shall occur on or before May 31, 2002. 
  
 6.    Conditions to Effectiveness of
Amendment.    This Amendment shall become effective upon the satisfaction of the following conditions precedent: 
  
 (a)    Administrative Agent shall have received a duly executed counterpart of this Amendment executed by the Borrower and the Required Lenders; 
  
 (b)    Administrative Agent shall have received duly executed counterparts of the Reaffirmation of Guarantee in the form attached hereto, executed by
each Subsidiary Guarantor; and 
  
 (c)    Borrower shall have paid all other fees and reasonable
costs and expenses of the Arranger and the Administrative Agent incurred in connection with this Amendment, including without limitation the reasonable fees and out-of-pocket expenses of counsel to the Administrative Agent. 
  
 7.    Representations and Warranties.    The Borrower hereby represents and warrants to the
Administrative Agent and Lenders that: 
  
 (a)    the execution, delivery and performance of this
Amendment (i) is within Borrower’s corporate power; (ii) has been duly authorized by all necessary corporate and shareholder action; (iii) does not require the consent, approval, authorization of, or registration or filing with, any Person
under any material Contractual Obligation, with any Person under the organizational documents of Borrower or any Subsidiary Guarantor, or with any Governmental Authority other than such consents, approvals, authorizations, registrations or filings
which have been made or obtained and are in full force and effect, and (iv) will not violate any Requirement of Law or cause a breach or default under Borrower’s or any Subsidiary Guarantor’s Contractual Obligations or organizational
documents except as could not reasonably be expected to have a Materially Adverse Effect; 
  
 (b)    this Amendment has been duly executed and delivered for the benefit or on behalf of Borrower and constitutes the legal, valid and binding obligation of Borrower, enforceable against it in accordance with
its terms, except as the enforceability hereof may be limited by bankruptcy, insolvency, reorganization, moratorium and other laws affecting creditors’ rights and remedies in general, and by general principles of equity; and 

 4 

  
 (c)    after giving effect to this Amendment, all of the
representations and warranties set forth in Article IV of the Credit Agreement, except for changes expressly permitted herein and except to the extent such representations and warranties relate solely to an earlier date, are true and correct in all
material respects and no Default or Event of Default has occurred and is continuing as of the date hereof. 
  
 8.    Survival.    Except as expressly provided herein, the Credit Agreement shall continue in full force and effect, and the unamended terms and conditions of the Credit Agreement are
expressly incorporated herein and ratified and confirmed in all respects. This Amendment is not intended to be or to create, nor shall it be construed as, a novation or an accord and satisfaction. 
  
 9.    Effect of Amendment.    From and after the date hereof, references to the Credit
Agreement shall be references to the Credit Agreement as amended hereby. 
  
 10.    Entire
Understanding.    This Amendment constitutes the entire agreement between the parties hereto with respect to the subject matter hereof. Neither this Amendment nor any provision hereof may be changed, waived, discharged,
modified or terminated orally, but only by an instrument in writing signed by the parties required to be a party thereto pursuant to Section 12.02 of the Credit Agreement. 
  
 11.    GOVERNING LAW.    THIS AMENDMENT SHALL BE CONSTRUED IN ACCORDANCE WITH AND BE GOVERNED BY THE LAW (WITHOUT GIVING
EFFECT TO THE CONFLICT OF LAW PRINCIPLES THEREOF) OF THE STATE OF GEORGIA. 
  
 12.    Counterparts.    This Amendment may be executed in any number of counterparts and by the different parties hereto on separate counterparts, each of which when so executed and
delivered shall be an original, but all of which shall together constitute one and the same instrument. 
  
 [Signatures to
Follow on Next Page] 
  
 

 5 

  
 IN WITNESS WHEREOF, the parties have caused this Amendment to be duly
executed as of the date first above written. 
  
 
	 NDCHEALTH CORPORATION
 as Borrower
 
	 
	 By
 	 	  
 

	  	 	 Name: Randolph L.M. Hutto
 Title: Executive Vice President & CFO

 
  
  
  
  
  
  
 [SEAL] 
  
  
 

  
 
	 SUNTRUST BANK
 as Administrative Agent, as Issuing Bank, as
Swingline Lender and as a Lender
 
	 
	 By    
 	 	  
 

	  	 	 Name:
 Title:
  
 

 
  
  
  
  
  
 

  
 
	 BANK OF AMERICA, N.A., as Syndication Agent
 
	 
	  	 	  
	 By
 	 	  
 

	  	 	 Name:
 Title:
 

 
  
  
  
 

  
 
	 WACHOVIA BANK, NATIONAL ASSOCIATION, as Co-Documentation Agent
 
	 
	 By
 	 	  
	  	 	 
Name:
 
	  	 	 Title:
 

 
  
  
  

  
 
	 U.S. BANK, NATIONAL ASSOCIATION,
 as Co-Documentation
Agent
 
	 
	 By
 	 	  
	  	 	 
Name:
 
	  	 	 Title:
 

 
  
  
  

  
  
 
	 LASALLE BANK, N.A., as a Lender
 
	 
	 By
 	 	  
	  	 	 
Name:
 
	  	 	 Title:
 

 

  
 
	 KEY CORPORATE CAPITAL, INC.,
 as a Lender
 
	 
	 By
 	 	  
	  	 	 
Name:
 
	  	 	 Title:
 

 

  
 
	 REGIONS BANK, as a Lender
 
	 
	 By
 	 	  
	  	 	 
Name:
 
	  	 	 Title:
 

 
  

  
 
	 COMERICA BANK, as a Lender
 
	 
	 By
 	 	  
	  	 	 
Name:
 
	  	 	 Title:
 

 

  
 ACKNOWLEDGMENT OF GUARANTORS 
  

Each of the undersigned, being a Subsidiary Guarantor of the Obligations of NDCHealth Corporation (“Borrower”) to the Lenders (as defined below) under that
certain Revolving Credit Agreement, dated as of May 1, 2002 (as further amended, restated, supplemented, or otherwise modified from time to time, the “Credit Agreement”; capitalized terms used herein but not defined herein shall have the
respective meanings assigned to such term in the Credit Agreement) by and among the Borrower, SunTrust Bank, (“SunTrust”), the other banks and lending institutions from time to time party thereto (SunTrust and such other banks and lending
institutions, individually a “Lender” and collectively, the “Lenders”), SunTrust in its capacity as Administrative Agent for the Lenders (the “Administrative Agent”), as Issuing Bank (the “Issuing Bank”), and
as Swingline Lender (the “Swingline Lender”), Bank of America, N.A., in its capacity as Syndication Agent (the “Syndication Agent”), and Wachovia Bank, National Association and U.S. Bank National Association, in their capacities
as Co-Documentation Agents (the “Co-Documentation Agents”), hereby (a) acknowledges its receipt of a copy of the within and foregoing First Amendment to Revolving Credit Agreement (“First Amendment”), (b) consents thereto and
agrees to be bound thereby and (c) agrees that its guaranty of the Obligations of Borrower to the Lenders shall continue in full force and effect from and after the execution and delivery by Borrower and the Lenders of the First Amendment, without
diminution or impairment. 
  
 IN WITNESS WHEREOF, each of the undersigned has caused this acknowledgment to be
executed under seal by their respective officers thereunto duly authorized, as of May 23, 2002. 
  
 
	 NDC HEALTH INFORMATION SERVICES (ARIZONA) INC., as Guarantor
 
	 
	 By:
 	 	  
 

	  	 	 Name: Randolph L.M. Hutto
 Title: Executive Vice President & CFO

 
  
  
 
	 SOURCE INFORMATICS INC., as Guarantor
 
	 
	 By:
 	 	  
 

	  	 	 Name: Randolph L.M. Hutto
 Title: Executive Vice President & CFO

 
  
  
 
	 THE COMPUTER PLACE, INC., as Guarantor
  
 
	 
	 By:
 

 	 	  
 

	  	 	 Name: Randolph L.M. Hutto
 Title: Executive Vice President & CFO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00042-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00042-of-00352.parquet"}]]